naion glp 1 GLP-1 receptor agonists are transforming metabolic care. Ophthalmologists now need to understand the ocular signals emerging around these drugs., The strongest safety discussion involves diabetic Optic Nerve Stroke and NAION
Description
doi: 10.1007/s10549-011-1585-0 [DOI] [PubMed] [Google Scholar] 54
Often, weight regain happens when medication is the only tool being used
When the receptor is activated by the chemical (such as a weight loss medication like a GLP-1), activates it induces the action or response that the receptor is programmed to do
Not all at once: 20 pounds here, 10 pounds there
The GLP-1 response from collagen consumption is modest compared to what pharmaceutical GLP-1 receptor agonists produce
Oral users see more variation between doses because the within-subject variability in bioavailability is roughly 137% for individual doses
